Andrew Arno, Director at Oncocyte Corp (OCX), bought 67,796 shares at $2.95 ($200K) on 2024-04-11, disclosed to the SEC on 2024-04-15.
Open-market purchase of $200k OCX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.95 | 33,898 | $100K | 50.0% |
| 2 | $2.95 | 33,898 | $100K | 50.0% |
| Total | $2.95 avg | 67,796 | $200K | 100% |
| Filing → |
| OCX | BUY | 2022-12-28 | $88K | — | Filing → |
| SMSI | BUY | 2022-08-22 | $64K | — | Filing → |
| OCX | BUY | 2022-08-19 | $7K | — | Filing → |